nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.058	0.0591	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.0444	0.0452	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.0431	0.0439	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0389	0.0396	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0351	0.0358	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0309	0.0315	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0303	0.0309	CbGpPWpGaD
Bisacodyl—GPR55—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.0281	0.0286	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.0264	0.0269	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.0236	0.024	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.0231	0.0235	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0231	0.0235	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.021	0.0214	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0208	0.0212	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0204	0.0208	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.0202	0.0205	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0198	0.0202	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.0188	0.0191	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0184	0.0187	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.018	0.0183	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0171	0.0174	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0165	0.0168	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0163	0.0165	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0161	0.0163	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.016	0.0163	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.015	0.0152	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.014	0.0142	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0133	0.0136	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.013	0.0133	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.013	0.0132	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0126	0.0128	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0124	0.0126	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0122	0.0124	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0121	0.0123	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0118	0.0121	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.0114	0.0116	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0106	0.0108	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.0105	0.0107	CbGpPWpGaD
Bisacodyl—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.0101	0.572	CrCbGaD
Bisacodyl—GPR55—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00904	0.0092	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00831	0.00846	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00821	0.00836	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00797	0.00812	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.0079	0.00804	CbGpPWpGaD
Bisacodyl—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00753	0.428	CrCbGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00735	0.00748	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00718	0.0073	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00714	0.00727	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00712	0.00724	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.007	0.00712	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00699	0.00712	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00691	0.00703	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00686	0.00698	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00667	0.00679	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00646	0.00658	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00643	0.00655	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00635	0.00646	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00627	0.00638	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00584	0.00595	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00485	0.00494	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00451	0.00459	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00424	0.00432	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00409	0.00417	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00394	0.00401	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00382	0.00389	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00375	0.00382	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00371	0.00377	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00345	0.00351	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00242	0.00246	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00128	0.0013	CbGpPWpGaD
